0.8705USD+1.22%Mkt Cap: 166.62M USDP/E: —Last update: 2026-05-26
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer,…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap166.62M USD
Enterprise Value262.80M USD
Revenue (TTM)150.71M USD
Gross Profit113.56M USD
Net Income (TTM)-20.20M USD
Revenue/Share0.8580 USD
Last Price0.8705 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees128
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4277461020
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-32.19
EV/Revenue1.74
P/S1.09
P/B20.26
EPS (TTM)-0.18
EPS (Forward)0.00
52W Range
0.74008% of range2.300
52W High2.300 USD
52W Low0.7400 USD
Profitability
Gross Margin73.31%
Oper. Margin-13.73%
EBITDA Margin-5.42%
Profit Margin-13.04%
ROE-140.90%
ROA-7.89%
Growth
Revenue Growth-10.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.59M USD
CapEx (TTM)317.00K USD
FCF Margin-12.24%
FCF Yield-11.07%
Net Debt96.85M USD
Net Debt/EBITDA-11.86
Balance Sheet
Debt/Equity9.81
Current Ratio2.53
Quick Ratio1.42
Book Value/Sh0.0430 USD
Cash/Share0.2370 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJan 13, 2014
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)3.667 USD
Target Range3.000 USD – 4.000 USD
# Analysts3
Ownership
Shares Out.189.28M
Float135.62M
Insiders0.88%
Institutions83.29%
Short Interest
Short Ratio21.4d
Short % Float27.65%
Short % Out.21.67%
Shares Short40.88M
Short (prev mo.)39.42M
Technical
SMA 500.9512 (-8.5%)
SMA 2001.188 (-26.7%)
Beta1.71
S&P 52W Chg28.31%
Avg Vol (30d)2.38M
Avg Vol (10d)2.65M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—